Eli Lilly and Co’s Revenue by Segment (2016-2018)

Exclusive Data

You need the Pro Plan for unlimited access.

Pro Plan

$49 per month*

60% discount ends in:

00
Days
00
Hours
00
Mins.
00
Seconds

.

Download

About

This statistic highlights Eli Lilly and Co’s Revenue by Segment from Q1 2016 onwards, split between Animal Health Products and Human Pharmaceuticals, reported on a quarterly basis.
Subscribe to Pro or Enterprise plans to unlock this feature.
More information
Subscribe to Pro or Enterprise plans to unlock this feature.
Contact the Analyst
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on reddit
Share on facebook
Share on twitter
Share on linkedin
Share on email

Become a smarter investor today.

Access Business Quant for as low as $19/month

Become a smarter investor today.

Access KPIs & Segment Financials on US stocks

This statistic highlights Eli Lilly and Co’s Revenue by Segment from Q1 2016 onwards, split between Animal Health Products and Human Pharmaceuticals, reported on a quarterly basis.

The company sells most of its products worldwide. It adapts its marketing methods and product emphasis in various countries to meet local customer needs and comply with local regulations. Their products are available in over 120 countries. The total Revenue of the company has been rising continuously since 2014. It experienced a little drag down in 2018 compared to 2017 but it has been rising significantly since 2018.  The company’s Revenue is further bifurcated into the following segments.

Eli Lilly and Co’s Revenue by Segment

Eli Lilly and Co’s Revenue by Segment Q4 2017 Q3 2018 Q4 2018 Contribution in Q4 2018
Animal Health Products $8 $8 $9 14%
Human Pharmaceuticals $4 $53 $57 86%
Total $12 $61 $66 100%

(All figures are in billions, except percentage)

Eli Lilly & Corporation Revenue by Segment increases by YOY and QOQ basis. Earlier in Q4 2017 company holds a revenue of $12 billion while in next year Q4 2018 it jumped to $66 billion showing an increase of 450%. The company’s animal health products show revenue holding by 14% only while the rest of the revenue is coming from human pharmaceuticals is 86%.

However, there is a rise in quarterly business revenue also, in Q3 2018 animal health products hold $8 billion while next year shows a rise of 12.5% that changes the figure to $9 billion in Q3 2021, for human pharmaceuticals. Every year licensed animal health products to hold around 15% of the revenue other hand rest is held by human pharmaceuticals which is 0f 85%.

Animal Health Products

Animal Health Products are defined to include all the  pharmaceutical, biological and medicinal, including in feed, products that are intended to enhance the health or performance of any and all species of animals, including livestock and  the companion animals but excluding humans, but to exclude (i) any products with the different intended utility, (ii) the nutritional additives, (iii) the chemical intermediates,

The company shows immense up and down in revenue by segment in Animal Health Products. Earlier in 2017 company holds a total of $8 billion in Q4 2017, while in the year Q4 2018 it rises to $9 billion. This shows there 12.5% rise in revenue in this segment of the company.

Human Pharmaceuticals

Human Pharmaceuticals is a kind of  prescription medicine unit which focuses on various therapeutic areas. Through its info related to  Diabetes, Oncology, Cardiovascular and Respiratory portfolios, Boehringer Ingelheim MENA aims to bring solutions to the patients that will improve the quality of life. Stroke prevention and treatment is one of the main focus areas in the region, where hospitals aim at enhancing stroke management, raising awareness hoping at saving lives through innovative solutions.

The company shows immense up and down in revenue by segment in Human Pharmaceuticals. Earlier in 2017 company holds a total of $4 billion in Q4 2017, while in the year Q4 2018 it rises to $57 billion. This shows there 1325% rise in revenue in this segment of the company.

About the Company

Eli Lilly and Company was incorporated in 1901 in Indiana to succeed in the drug manufacturing business founded in Indianapolis, Indiana, in 1876 by Colonel Eli Lilly. They specialize on one business segment: human pharmaceutical products, which they research, develop, manufacture, and market. In March 2019, they completed the disposition of their ownership in Elanco Animal Health Incorporated (Elanco), an animal health business.

Their purpose is to unite caring with discovery to create medicines that make life better for people around the world. Most of the products they sell today were discovered or developed by their scientists, and their long-term success depends on their ability to continually discover or acquire, develop, and commercialize innovative new medicines.

Did you like Eli Lilly and Co’s Revenue by Segment statistic?

Access more such key performance indicator (KPI) data points and segment financials, on thousands of US stocks, with Business Quant.

You can get started here.

Read more

Access Segment financials and KPI data on US stocks

Our Plans

Always know what you’ll pay. No hidden costs or surprises.

  • Annual
  • Monthly

Basic

Get to know us

  • Access only basic data
  • This statistic is not included The statistic that you're currently viewing, is not included in the Basic plan. Please subscribe to the Pro plan to access this statistic.
$0
per month
Start for Free

60% discount until May 31

Pro

For serious investing

  • This statistic is included Instant access to all the data and features on the Business Quant platform. This also includes access to the statistic that you're currently viewing.
  • Granular KPI data Access segment financials, non-GAAP metrics and KPI data from presentations and filings. Examples include financials by segment / region / product category, AT&T's broadband subscriber trends, Tesla's deliveries by model and lots more.
  • Stock research tools Features include : Stock screener, Stock comparison, sector financials, stock warnings, advanced charting tools, financial statements dating back 10+ years, stock reports, SEC filings and stock ratings. There are 200+ financial items and ratios on thousands of US stocks.
  • Industry data & tools Access premium operating data on 40+ industries. Examples include market share, smartphone shipments by vendor, subscribers by wireless carrier, historical gold production. There are 20,000+ such statistics.
$49
$19
per month*
Buy Now

Enterprise

For tailored workflows

  • All of Pro plan Get unfettered access to all our dashboards and dossiers.
  • Custom built features Get tailored dashboards built specially for you , based on your set of requirements, to simplify your research workflow.
$99
per month, onwards*
Contact Us

* Billed annually, local taxes extra. 

Basic

Get to know us

  • Access only basic data
  • This statistic is not included The statistic that you're currently viewing, is not included in the Basic plan. Please subscribe to the Pro plan to access this statistic.
$0
per month
Start for Free

60% discount on Annual plan

Pro

For serious investing

  • This statistic is included Instant access to all the data and features on the Business Quant platform. This also includes access to the statistic that you're currently viewing.
  • Granular KPI data Access segment financials, non-GAAP metrics and KPI data from presentations and filings. Examples include financials by segment / region / product category, AT&T's broadband subscriber trends, Tesla's deliveries by model and lots more.
  • Stock research tools Features include : Stock screener, Stock comparison, sector financials, stock warnings, advanced charting tools, financial statements dating back 10+ years, stock reports, SEC filings and stock ratings. There are 200+ financial items and ratios on thousands of US stocks.
  • Industry data & tools Access premium operating data on 40+ industries. Examples include market share, smartphone shipments by vendor, subscribers by wireless carrier, historical gold production. There are 20,000+ such statistics.
$49
per month*
Buy Now

Enterprise

For tailored workflows

  • All of Pro plan Get unfettered access to all our features.
  • Custom built features Get tailored dashboards built specially for you , based on your set of requirements, to simplify your research workflow.
$99
per month, onwards*
Contact Us

* Local taxes extra. 

BQ Star Yellow 60%

Get Pro for 60% off

  • Access all features immediately
  • Datasets updated every day
  • Export data in CSV and XLSX formats

Offer Ends In

Starting from $49 $19 / month

.